GRF

Peers: CRF QQQX RMT SWZ CLM

Index	-
Market Cap	39.56M
Enterprise Value	-
Income	-
Sales	-
Book/sh	-
Cash/sh	-
Dividend Est.	-
Dividend TTM	0.09 (0.90%)
Dividend Ex-Date	Nov 21, 2025
Dividend Gr. 3/5Y	-36.04% 10.76%
Payout	-
Employees	-
IPO	Aug 26, 1994

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	-
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	15.00%
Insider Trans	4.67%
Inst Own	2.51%
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-0.21%
SMA50	-2.68%
SMA200	-3.11%
Trades

Shs Outstand	3.97M
Shs Float	3.37M
Short Float	0.05%
Short Ratio	0.44
Short Interest	0.00M
52W High	11.85 -15.86%
52W Low	9.49 5.03%
Volatility	1.73% 1.65%
ATR (14)	0.25
RSI (14)	46.59
Beta	0.24
Rel Volume	0.01
Avg Volume	3.65K
Volume	35

Perf Week	-0.60%
Perf Month	-1.97%
Perf Quarter	-3.95%
Perf Half Y	-1.29%
Perf YTD	-6.82%
Perf Year	-0.06%
Perf 3Y	28.42%
Perf 5Y	28.82%
Perf 10Y	109.84%
Recom	-
Target Price	-
Prev Close	9.97
Price	9.97
Change %	0.00%

May-05-25 04:30AM	JCE: Difficult To Recommend This Fund At The Current Price (Seeking Alpha)
Apr-19-25 11:38AM	GAM: Tech Exposure Could Mean Short-Term Pain (Seeking Alpha)
Nov-18-24 04:00PM	Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash (Business Wire)
Oct-13-23 05:30PM	Eagle Capital Growth Fund Declares Year-End Distribution of $0.35 Per Share in Cash (Business Wire)
Apr-18-23 10:30AM	Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023 (PR Newswire)
05:00PM	Loading…
Oct-14-22 05:00PM	Eagle Capital Growth Fund Declares Year-End Distribution of $0.37 Per Share in Cash (Business Wire)
Apr-06-22 05:24PM	Green Rise Foods Announces Acquisition of 16-Acre Greenhouse and Provides Update on the Outlook for Its Fiscal 2022 Crop (Newsfile)
Dec-17-21 08:38PM	Baillie Gifford International Alpha Fund Buys Hangzhou Tigermed Consulting Co, WuXi Biologics ... (GuruFocus.com)
Nov-08-21 05:05PM	Eagle Capital Growth Fund Declares Year-End Distribution of $0.97 Per Share (Business Wire)
Aug-19-21 04:01PM	Eagle Capital Growth Fund Elects Anne M. Nichols, CFA as Director; Expands Stock Repurchase Authority (Business Wire)
Apr-15-21 01:53PM	Eagle Capital Growth Fund Elects New Director Jason W. Allen, and Bids Farewell to Retiring Director Peggy L. Schmeltz (Business Wire)
Dec-07-20 05:20PM	Eagle Capital Growth Fund Opts Into Maryland Control Share Acquisition Act (Business Wire)
Nov-23-20 04:32PM	Eagle Capital Growth Fund Declares Year-End Distribution of $0.55 Per Share (Business Wire)
Jul-21-20 04:02PM	CPV Power Plant No.1 Bond SPV (RF) Limited -- Moody's announces completion of a periodic review of ratings of CPV Power Plant No.1 Bond SPV (RF) Limited (Moody's)
Feb-13-20 09:00AM	Grifols PharmacyKeeper ranked No. 1 in KLAS rating, extends category leadership (PR Newswire)
05:00PM	Loading…
Dec-26-19 05:00PM	Eagle Capital Growth Fund Finalizes Year-End Distribution of $0.56 Per Share (Business Wire)
Dec-12-19 09:24AM	Grifols launches XEMBIFY® (immune globulin subcutaneous human-klhw) 20%, a new Primary Immunodeficiency treatment (PR Newswire)
Dec-06-19 03:42PM	Grifols presents its latest Alzheimer's clinical trial data (PR Newswire)
Dec-05-19 10:26AM	Grifols Streamlines Hospital Pharmacy Operations With New KIRO Fill® Technology and PharmacyKeeper Enhancements (PR Newswire)
Dec-02-19 09:17AM	Grifols to present latest Alzheimer's clinical trial results (PR Newswire)
Nov-07-19 04:46PM	Eagle Capital Growth Fund Declares Year-End Distribution of $0.56 Per Share (Business Wire)
10:00AM	Grifols introduces AlphaID, a free cheek swab to screen for Alpha-1, the most common genetic form of COPD (PR Newswire)
Oct-03-19 04:54PM	CPV Power Plant No.1 Bond SPV (RF) Limited -- Moody's announces completion of a periodic review of ratings of CPV Power Plant No.1 Bond SPV (RF) Limited (Moody's)
Jul-16-19 02:39AM	Grifols presents additional encouraging Alzheimer's trial results at AAIC (PR Newswire)
Jul-04-19 11:51AM	Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies (PR Newswire)
Jul-03-19 05:00AM	Grifols Selected to Build Its First Intravenous Solutions Manufacturing Line in Africa (PR Newswire)
Jun-19-19 09:00AM	Grifols to launch plasma-protein-based bleeding-control solutions (PR Newswire)
Jun-06-19 06:00AM	How International Is Your Foreign-Stock Fund? (Morningstar)
Apr-30-19 06:00AM	Grifols Announces PharmacyKeeper Bidirectional Integration with Epic (PR Newswire)
Apr-29-19 12:00PM	Grifols Announces the Opening of its new Plasma Donor Center in Hinesville, Georgia (PR Newswire)
09:00AM	Loading…
Apr-18-19 09:00AM	Grifols US donor centers exceed 250,000 pounds of food collected (PR Newswire)
Apr-15-19 06:15AM	Grifols donations of blood clotting factor helping people with hemophilia globally (PR Newswire)
Apr-05-19 10:55AM	Grifols 2018 Annual Report on Form 20-F Filed With the SEC on April 5, 2019 (PR Newswire)
Feb-07-19 12:31PM	Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System (PR Newswire)
Jan-23-19 07:30AM	Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe (PR Newswire)
Jan-08-19 07:37AM	Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions (PR Newswire)
Dec-28-18 04:15PM	Eagle Capital Growth Fund Finalizes Year-End Distribution of $0.53 Per Share (Business Wire) +11.11%
Nov-07-18 04:45PM	Eagle Capital Growth Fund Declares Year-End Distribution of $0.53 Per Share (Business Wire)
Oct-27-18 03:30AM	Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol (PR Newswire)
Oct-12-18 09:50AM	FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing (PR Newswire)
Oct-08-18 02:57PM	Grifols Delivers Promise of Advancing Plasma-derived Medicines through Innovative Vision and Donor Support (PR Newswire)
Sep-24-18 12:59PM	Grifols Announces the Opening of Biotest Pharmaceuticals Corporation's Newest Plasma Donor Center in Bowling Green, Ohio (PR Newswire)
Aug-14-18 08:00AM	Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System (PR Newswire)
May-31-18 09:00AM	Grifols Launches a New Testing Service for Patients Treated with Daratumumab (PR Newswire)
May-14-18 08:00AM	Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents (PR Newswire)
Apr-16-18 11:21AM	Grifols donates over 25 million international units of blood clotting factor in 2017 (PR Newswire)
Dec-28-17 04:15PM	Eagle Capital Growth Fund Finalizes Year-End Distribution of $0.51 Per Share (Business Wire)
Dec-04-17 08:00AM	Grifols Misterium® Cleanroom Solutions Expands to Include Revolutionary Decontamination Air and Surface Disinfection Systems for Pharmaceutical Preparation (PR Newswire)
Nov-29-17 10:32AM	Kenya set to build coast-to-centre highway to boost Africa trade (Reuters)
Nov-06-17 04:15PM	Eagle Capital Growth Fund Declares Year-End Distribution of $0.51 Per Share (Business Wire)
Aug-22-17 08:00AM	Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces (PR Newswire)
Aug-01-17 08:00AM	Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol (PR Newswire)
Jul-28-17 02:50PM	Grifols SA : One of the better choices within its peer group (Capital Cube)
Jun-22-17 03:11PM	Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples (PR Newswire)
May-23-17 12:07PM	South Africa's Group Five names Mosai as new CEO (Reuters)
May-09-17 02:13PM	Grifols SA : Fairly valued, but dont skip the other factors (Capital Cube)
Apr-24-17 08:00AM	Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility (PR Newswire)
Apr-04-17 09:11AM	Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017 (PR Newswire)
Mar-08-17 04:16PM	Grifols SA : Fairly valued, but dont skip the other factors (Capital Cube)
Jan-31-17 04:05PM	Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million (PR Newswire)
04:01PM	Hologic Completes Divestiture of Blood Screening Business (PR Newswire)
Dec-28-16 04:01PM	Eagle Capital Growth Fund Finalizes Year-End Distribution of $1.19 Per Share (Business Wire) -5.58%
Dec-14-16 04:15PM	Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million (PR Newswire)
04:01PM	Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion (PR Newswire)
Nov-07-16 04:01PM	Eagle Capital Growth Fund Declares Year-End Distribution of $1.19 Per Share (Business Wire)
Sep-05-16 05:32AM	Grifols Opens Diagnostic Training Center in Dubai (PR Newswire)
Jul-22-16 03:18AM	Greiffenberger AG :GRF-DE: Earnings Analysis: For the six months ended December 31, 2015 : July 22, 2016 (Capital Cube)
Jul-12-16 04:06PM	Grifols SA : Neutral outlook but great fundamentals (Capital Cube)
Jun-20-16 08:00AM	FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol (PR Newswire)
May-23-16 03:39AM	Greiffenberger AG :GRF-DE: Earnings Analysis: For the six months ended December 31, 2015 : May 23, 2016
May-10-16 11:36AM	CPV Power Plant No.1 Bond SPV (RF) Limited -- Moody's recalibrates South Africa's national rating scale and affirms Baa2.za rating of CPV Power Plant No.1 Bond SPV (RF) Limited; outlook stable (Moody's)
Apr-28-16 04:05PM	Grifols SA : Neutral outlook but great fundamentals
Jan-27-16 07:44AM	Press Release, January 25, 2016 (noodls)
Jan-26-16 07:29AM	Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV (noodls) +5.03%
07:29AM	Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV Download (249.7 Kb) (noodls)
Dec-29-15 04:01PM	Eagle Capital Growth Fund Finalizes Year-End Distribution of $0.50 Per Share (Business Wire)
Nov-09-15 04:05PM	Eagle Capital Growth Fund Declares Year-End Distribution of $0.50 Per Share (Business Wire)
Oct-20-15 12:30PM	Grifols SA : Overvalued relative to peers, but may deserve another look
Aug-12-15 11:59AM	Grifols SA : Overvalued relative to peers, but good fundamentals
May-14-15 04:31PM	Grifols SA : Undervalued relative to peers?

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sims David C	CFO, CCO, Secretary, Treasurer	Oct 16 '26	Buy	10.05	8,806	88,506	228,838	Oct 20 01:18 PM
Sims David C	CFO, CCO, Secretary, Treasurer	Oct 16 '26	Buy	10.16	1,981	20,127	29,882	Oct 20 01:18 PM
SIMS LUKE E	President & CEO	Sep 01 '26	Buy	9.99	2,560	25,575	297,827	Sep 03 04:41 PM
Sims David C	CFO, CCO, Secretary, Treasurer	May 22 '26	Buy	10.00	10,000	99,980	220,032	May 27 04:41 PM
SIMS LUKE E	President & CEO	May 18 '26	Buy	10.20	1,209	12,332	295,267	May 19 03:08 PM
Tyler Donald G	Director	May 11 '26	Buy	10.05	1,000	10,050	9,945	May 13 03:45 PM
Tyler Donald G	Director	Apr 16 '26	Buy	9.90	1,000	9,900	8,059	May 05 11:44 AM
Zalenko Neal F.	Director	Feb 10 '26	Buy	11.09	1,400	15,526	21,617	Feb 12 09:19 PM
Zalenko Neal F.	Director	Feb 12 '26	Buy	10.99	1,000	10,990	22,617	Feb 12 09:19 PM
Zalenko Neal F.	Director	Feb 02 '26	Buy	10.80	500	5,400	20,217	Feb 04 05:42 PM
Zalenko Neal F.	Director	Jan 09 '26	Buy	10.84	427	4,629	18,895	Jan 14 01:34 PM
Zalenko Neal F.	Director	Jan 13 '26	Buy	11.00	234	2,574	19,129	Jan 14 01:34 PM
Zalenko Neal F.	Director	Dec 01 '25	Buy	10.00	1,000	10,000	17,838	Dec 03 05:15 PM
Zalenko Neal F.	Director	Dec 02 '25	Buy	10.00	25	250	17,863	Dec 03 05:15 PM
Zalenko Neal F.	Director	Nov 25 '25	Buy	10.13	1,000	10,130	16,838	Nov 28 05:43 PM
Zalenko Neal F.	Director	Nov 17 '25	Buy	10.80	1,000	10,800	15,327	Nov 19 05:05 PM
Zalenko Neal F.	Director	Nov 18 '25	Buy	10.64	511	5,437	15,838	Nov 19 05:05 PM
Zalenko Neal F.	Director	Nov 07 '25	Buy	10.65	1,000	10,650	14,327	Nov 12 04:58 PM

Eagle Capital Growth Fund, Inc. is a closed-end equity mutual fund launched and managed by Sims Capital Management LLC. The fund invests in the public equity markets of the United States. It makes its investments in the stocks of companies operating across diversified sectors. The fund benchmarks the performance of its portfolio against the S&P 500 Index. It was previously known as NAIC Growth Fund, Inc. Eagle Capital Growth Fund, Inc. was formed on April 11, 1989 and is domiciled in the United States.

Chief Executive OfficerMr. Luke Edward Sims

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Eagle Capital Growth Fund Inc

Upgrade your Finviz experience